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VALORIZATION ADDENDUM
SOCIAL RELEVANCE
Obesity is today’s most obvious visible health problem. Obesity is escalating and 
has become a global epidemic. The prevalence of obesity has more than doubled 
between 1980 and 2015, and without proper interventions, the prevalence of 
obesity-related conditions is likely to increase as obesity continues to rise in the 
next few decades. At present, at least 2.8 million people die prematurely each year 
as a result of being overweight or obese (WHO report March 2013). The health 
consequences of obesity are related to metabolic diseases, such as type 2 diabetes, 
cardiovascular disease, hypertension, stroke and certain types of cancer. Next to 
the metabolic complications, obesity also has social and psychological dimensions 
affecting essentially all ages and socioeconomic groups. Taken together, obesity 
and its complications can dramatically impair quality of life and have a big impact 
on health care costs. Therefore, it is important with immediate action to slow down 
or stop the global obesity epidemic and its complications. In this context a better 
understanding of the underlying cause of obesity related complications is needed 
and could result in the development of more specific therapeutic or preventive 
strategies for people at risk. 
TARGET GROUPS
The obesity epidemic is a result of people consuming high caloric diets and being 
physically inactive. This results in an imbalance between calories consumed and 
calories expended, and hence a positive energy balance. This positive energy 
imbalance leads to an excessive accumulation of fat not only in adipose tissue, but 
also in non-adipose tissues (ectopic fat accumulation), such as skeletal muscle, liver 
and heart. In contrast to the fat stored in adipose tissues, the fat stored in the non-
adipose tissue is associated with the development of insulin resistance and type 2 
diabetes. Therefore, to slow down the development of obesity related complications, 
such as type 2 diabetes, it is essential to gain a better understanding of why lipids 
store in these tissues and what the consequences of ectopic fat storage are. 
Because obesity affects millions of people worldwide and leads to exploding 
healthcare costs, the search for novel strategies to counteract obesity and its 
complications is important for the general public, and especially for those at risk 
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of developing overweight- and obesity related complications. In this context, 
discovery of novel therapies and treatments might lead to an improvement of quality 
of life and long-term health, but also to saving health care costs by e.g. reduced 
hospitalization. Therefore it is important for obesity and diabetes management 
that the communication between researchers and health institutions, health care 
professionals and the general population, is good, so that knowledge can be shared. 
ACTIVITIES AND PRODUCTS
The studies described in this thesis have been conducted at the department of 
Human Biology of Maastricht University Medical Center+. In order to investigate 
the causes and consequences of ectopic fat accumulation, some studies were 
done in collaboration with the department of Radiology of the University Hospital of 
Maastricht. This collaboration was essentially, as the current technique to measure 
ectopic fat in skeletal muscle, liver and heart non-invasively with Magnetic Resonance 
Spectroscopy (MRS) was only available in the hospital. All studies outlined in this 
thesis were conducted in human volunteers and different interventions were applied 
to manipulate e.g. plasma free fatty acid levels. Both in vivo and ex vivo state-of-
the-art techniques, such as MRS and high-resolution respirometry, were applied to 
unravel why fat is stored in non-adipose tissues and what the consequences are. 
The results described in this thesis have been implemented in original research 
articles that have been published or submitted to scientific journals in the field of 
obesity and diabetes. These articles are to be found online and are accessible 
to other scientists. The present results have also been presented on international 
conferences and can be used for future studies.  
INNOVATION 
In obesity there is a failure in the capacity of appropriate adipose tissue expansion, 
which leads to an increased flux of free fatty acids away from rather than into adipose 
tissue resulting in an increased storage of fat in non-adipose tissues.  This increased 
influx of free fatty acids is believed to be harmful to the tissues, contributing to insulin 
resistance and type 2 diabetes, a process referred to as lipotoxicity. Alternatively, 
impaired oxidative capacity of the mitochondria could also be an underlying factor 
for ectopic fat accumulation, interestingly, a low mitochondrial function has also been 
linked to insulin resistance. In this thesis, we mainly focused on the role of FFA in this 
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ectopic fat accumulation and how this is linked to lipotoxicity, but also investigate 
mitochondrial function as a factor in lipotoxicity. We recruited human volunteers 
who underwent a combination of intervention studies, including manipulations of 
plasma FFA by acute exercise or administration of the antilipolytic-drug acipimox 
and manipulations of mitochondrial function and oxidative capacity by inactivity. 
Earlier, the heart and the liver were both inaccessible for human studies. However, 
due to a development of the non-invasive MRS technique and the implementation 
on clinical MRI scanners in recent years, we were able to intensively study the 
ectopic fat accumulation (with proton (1H) MRS) in skeletal muscle, liver and heart 
in both healthy volunteers and in people with type 2 diabetes. Additionally, applying 
phosphorous (31P) MRS enabled us to investigate the energy status of the heart and 
the liver and the in vivo mitochondrial function of skeletal muscle. Another strength 
of this thesis therefore is that we were able to measure ectopic fat accumulation 
in more tissues enabling a comparison between tissues. The excellent facilities of 
our lab also enabled us to investigate subjects’ substrate metabolism and insulin 
sensitivity in vivo by means of a ventilated hood and a 2-step hyperinsulinemic 
euglycemic clamp, respectively. Next to performing in vivo measurements, muscle 
biopsies were also withdrawn for ex vivo measurements of oxidative capacity, fat- 
and glucose metabolism and insulin signalling analysis. Oxidative capacity was 
measured with high-resolution respirometry (Oroboros oxygraph), fat- and glucose 
metabolism by 14C oxidation assays and insulin signaling by western blotting. 
The results provided us with valuable information on the role of FFA on ectopic 
fat accumulation and organ function. With the mentioned techniques we were 
able to show that plasma FFA levels are an important determinant for ectopic fat 
accumulation and that non-adipose tissues seem to take up plasma FFA from the 
circulation when the availability is high, independent of oxidative needs. However, 
we could not show that ectopic fat accumulation always leads to organ dysfunction 
and more research is necessary to answer this. The results of this thesis can be 
used for future studies focusing on the relevance of fat accumulation and lipotoxicity 
for the etiology of type 2 diabetes in humans. 
PLANNING AND REALIZATION
In this thesis, human intervention studies have been used to study the role of free fatty 
acids in ectopic lipid accumulation. We demonstrated that plasma concentration of 
free fatty acids indeed is an important determinant for ectopic fat accumulation, 
but that an acute increase in ectopic fat depots did not necessarily lead to harmful 
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effects disturbing organ function. Thus, more research is warranted to unravel the 
relationship between elevated ectopic fat accumulation and tissue dysfunction. In 
“The Diabetes and Metabolism Research Group” of Prof. dr. P. Schrauwen and Prof. 
dr. M. Hesselink, this relationship will further be explored by performing translational 
research. To this end high-end molecular and cellular biology tools and non-invasive 
and microscopically imaging and spectroscopy will be combined with state-of-the-
art metabolic phenotyping in a predominantly experimental human research setting. 
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